CN Stock MarketDetailed Quotes

688202 Shanghai Medicilon Inc.

Watchlist

31.84
-0.30-0.93%

Market Closed Dec 27 15:00 CST

4.29BMarket Cap-15.49P/E (TTM)

Shanghai Medicilon Inc. Stock Forum

Moomoo AI

Mar 5 17:34

Shanghai Medicilon's conservative liability management and light debt load are overshadowed by its loss-making status and shrinking revenue. Despite this, its balance sheet doesn't seem overly risky currently, but may need more capital if break-even isn't reached soon.

Is Shanghai Medicilon (SHSE:688202) Using Too Much Debt?

Spinee

Jan 28 19:47

A bill to prohibit contracting with certain biotechnology providers, and for other purposes.

BGI, MGI, Complete Genomics, Wuxi Apptec, and any subsidiary are included.
Last Friday, WuXi AppTec's shares tumble by 20% in Hong Kong and fall by a 10% limit-down in mainland China.
Other CRO stocks including Medicilon are also falling.
$WUXI BIO (02269.HK)$ $WUXI APPTEC (02359.HK)$ $BGI Genomics (300676.SZ)$ $MGI Tech Co., Ltd. (688114.SH)$ $Shanghai Medicilon Inc. (688202.SH)$ $Novo-Nordisk A/S (NVO.US)$ $Hang Seng H-Share Index ETF (02828.HK)$

Moomoo AI

Jan 1 22:57

Analysts express skepticism despite investors expecting the company to reverse its trend and outperform. The unsustainable level of earnings growth may depress the stock price according to them.